Amia Capital’s Q32 Bio QTTB Stock Holding History

Amia Capital’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-781	Closed	-$218K	–	41
2020 Q1	$218K	Sell	781 -363	-32%	-$111K	0.19%	34
2019 Q4	$426K	Buy	+1,144	New	+$328K	0.12%	35

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amia Capital's QTTB Position: Q2 2020 in Review

Amia Capital sold out of Q32 Bio (QTTB) in Q2 2020, closing a stake of 781 shares — an estimated $218K sold.

Amia Capital first reported a position in QTTB in Q4 2019 and held it in 2 quarters. The position peaked at $426K in Q4 2019. 102 funds tracked by Wall St. Rank hold QTTB as of Q2 2020.

Amia Capital reported no remaining Q32 Bio position as of Q2 2020 after selling out during the quarter.
Amia Capital sold 781 Q32 Bio shares in Q2 2020, an estimated $218K.
Amia Capital first reported a position in Q32 Bio in Q4 2019 and held it in 2 quarters.
Amia Capital's Q32 Bio position peaked at $426K in Q4 2019.
102 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2020.

Based on Amia Capital's 13F filing for Q2 2020, filed 14 Aug 2020.